@felavi.center's peptide combo claims, fact-checked

What does this video actually claim?

The Felavi Center promotes their "GLOW" peptide combination containing three compounds: GHK-Cu for skin rejuvenation and hair growth, BPC-157 for tissue repair and inflammation, and TB-500 for wound healing and muscle recovery. They're positioning this as a comprehensive anti-aging and recovery solution.

The post targets people interested in aesthetic improvements and physical optimization. It's classic peptide marketing: take three trendy compounds and package them as a synergistic solution.

Does the science back this up?

The evidence is mixed and mostly preliminary. GHK-Cu has the strongest foundation, with studies like Pickart et al. (2012) in skin pharmacology showing improved collagen synthesis in vitro and small human trials demonstrating modest skin improvements.

BPC-157 research is almost entirely limited to animal studies. A 2020 review by Sikiric et al. in Current Pharmaceutical Design noted promising results in rats for tissue healing, but human data is practically nonexistent.

TB-500 (thymosin beta-4) has even less clinical support. Most research involves horse studies or small cell culture experiments. The FDA hasn't approved any of these peptides for cosmetic or recovery use.

What did they get wrong?

The biggest problem is presenting animal research as if it applies directly to humans. When they claim BPC-157 "accelerates tissue recovery," they're extrapolating from rat studies without acknowledging this gap.

They also oversell the certainty of results. Phrases like "improves skin quality" and "helps hair grow stronger" sound definitive when the human evidence is limited to small, short-term studies.

The combination approach lacks any research support. No studies have tested these three peptides together, so claims about "more complete results" are pure speculation.

What should you actually know?

Peptides operate in a regulatory gray area. They're not FDA-approved drugs, but they're not simple supplements either. Quality and dosing vary wildly between providers.

GHK-Cu shows the most promise for skin applications, but even positive studies show modest effects. A 2014 trial by Arul et al. found 30% improvement in skin firmness after 12 weeks, which is meaningful but not dramatic.

The cost-benefit calculation is questionable. These peptide cocktails often run hundreds of dollars monthly for effects that might be achievable with established treatments like retinoids or professional procedures.